Meeting
2020 ASCO Quality Care Symposium
An evaluation of adult cancer-related neuropathic pain treatment at a large academic medical center.
Authors
Elizabeth Kyung Ko
12850 E Montview Blvd, Aurora, CO
Elizabeth Kyung Ko, Ashley Elizabeth Glode, Garth C. Wright
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
On-Demand Poster Session: Patient Experience
Track
Patient Experience
Sub Track
Symptom Prevention, Assessment, and Management
Citation
J Clin Oncol 38, 2020 (suppl 29; abstr 168)
DOI
10.1200/JCO.2020.38.29_suppl.168
Abstract #
168
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 Palliative and Supportive Care in Oncology Symposium
Chemical coping and efficacy of buprenorphine for cancer pain.
First Author: Amy Allen Case
Poster
2011 ASCO Annual Meeting
Final results of a randomized phase II trial (NCT00637975) evaluating activity and toxicity of fixed-dose oxycodone and increasing dose of pregabalin versus increasing dose of oxycodone and fixed-dose pregabalin for the treatment of oncologic neuropathic pain (NEUROPAIN-01).
First Author: M. C. Garassino
Poster
2022 ASCO Quality Care Symposium
Prediction of daily pain and opioid consumption in hospitalized patients with cancer: The importance of psychological symptoms, previous pain, and opioid use.
First Author: Desiree Rachel Azizoddin
Poster
2021 ASCO Quality Care Symposium
Perioperative sleep disturbance following mastectomy: A longitudinal investigation of the relationship to pain, opioid use, treatment, and psychosocial symptoms.
First Author: Desiree Rachel Azizoddin